Клиномир в тестовом запуске. Кто с нами с первых дней, получит отметку «С первых дней» в профиле и первым увидит новые возможности сайта.

Зарегистрироваться
Каталог · ЕАЭС

Клинические исследования и проекты

Все исследования · найдено 18 503

Ищем по всем вариантам написания в реестрах, по-русски и по-английски. Спонсор или разработчик.
Статус
Что исследуют
Источник
Фаза
Страна
Участники
Кто может участвовать По критериям ClinicalTrials.gov. Исследования, где реестр возраст и пол не указывает, тоже показываются. Возраст и пол нигде не сохраняются.
Сбросить
18 503 исследования
Завершено Фаза III Россия
insulin detemir; insulin aspart; insulin detemir · Ново Нордиск А/С

A 12-months Multi-national, Multi-centre, Double Blind, Randomised, Parallel Safety and Efficacy Comparison of Insulin Detemir Produced by the Current Process and Insulin Detemir Produced by the NN729 Process in Subjects With Type 1 Diabetes on a Basal-bolus Regimen With Insulin Aspart as the Bolus Insulin

330 участников во всех странах ClinicalTrials.gov EX1729-1778
Завершено Фаза III Россия
insulin degludec/insulin aspart; insulin detemir; insulin aspart; insulin aspart · Ново Нордиск А/С

NN5401-3594: A 26-week, Open-labelled, Two-arm, Parallel, Randomised Trial Comparing Efficacy and Safety of NN5401 Once Daily Plus Insulin Aspart vs. Basal-bolus Treatment With Insulin Detemir Plus Insulin Aspart in Subjects With Type 1 Diabetes / NN5401-3645: An Extension Trial Comparing Safety and Efficacy of NN5401 Plus Meal-time Insulin Aspart for the Remaining Meals With Insulin Detemir Plus Meal-time Insulin Aspart in Type 1 Diabetes (BOOST™: T1)

548 участников во всех странах ClinicalTrials.gov NN5401-3594
Прекращено Здоровые добровольцы Россия
PSM · Atlas Biomed

Study of the Genome, Gut Metagenome and Diet of Patients With Incident Parkinson's Disease

Томск 1 центр 138 участников во всех странах ClinicalTrials.gov PSM
Завершено Фаза III Россия
Golimumab; methotrexate (MTX) · Centocor, Inc.

A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, an Anti-TNFalpha Monoclonal Antibody, Administered Intravenously, in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy

592 участника во всех странах ClinicalTrials.gov CR015784
Прекращено Фаза II Россия
E7070 · Эйсай Лимитед

An Open-label, Randomized, Phase II Study of the Efficacy and Safety of Indisulam (E7070) in Combination With Capecitabine Versus Capecitabine Monotherapy for the Treatment of Metastatic Breast Cancer Patients Following Prior Anthracycline and Taxane Therapy

Москва, Санкт-Петербург и ещё 5 городов 8 центров 62 участника во всех странах ClinicalTrials.gov E7070-E044-213
Завершено Фаза III Россия
ceftaroline; vancomycin plus aztreonam; Placebo · Forest Laboratories

A Phase 3, Multicenter, Randomized, Double-blind, Comparative Study to Evaluate the Safety and Efficacy of Ceftaroline Versus Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin and Skin Structure Infection (cSSSI)

680 участников во всех странах ClinicalTrials.gov P903-07
Прекращено Фаза II Россия
Cinaciguat (BAY58-2667); Cinaciguat (BAY58-2667); Cinaciguat (BAY58-2667); Placebo · Байер АГ

A Placebo Controlled, Randomized, Double-Blind, Fixed-dose, Multicenter, Phase IIb Study to Investigate the Efficacy and Tolerability of BAY58-2667 (150 µg/h, 100 µg/h, 50 µg/h) Given Intravenously to Subjects With Acute Decompensated Chronic Congestive Heart Failure (ADHF)

12 участников во всех странах ClinicalTrials.gov 14560
Завершено Фаза II Россия
Placebo; BI 1356 dose 3 once daily; BI 1356 dose 2 once daily; BI 1356 dose 1 once daily; Metformin · Boehringer Ingelheim

A Randomized, Double-blind, Placebo-controlled, Five Parallel Group Study Investigating the Efficacy and Safety of BI 1356 BS (0.5 mg, 2.5 mg and 5.0 mg Administered Orally Once Daily) Over 12 Weeks in Drug Naive and Treated Patients With Type 2 Diabetes With Insufficient Glycemic Control (Study Includes an Open-label Metformin Treatment Arm)

302 участника во всех странах ClinicalTrials.gov 1218.5
Завершено Фаза III Россия
Pramipexol Extended Release; Pramipexol Immediate Release; Placebo · Boehringer Ingelheim

A Double-blind, Double-dummy, Placebo-controlled, Randomized, Three Parallel Groups Study Comparing the Efficacy, Safety and Tolerability of Pramipexole Extended Release (ER) Versus Placebo and Versus Pramipexole Immediate Release (IR) Administered Orally Over a 26-week Maintenance Phase in L-Dopa+ Treated Patients With Advanced Parkinsons Disease (PD).

517 участников во всех странах ClinicalTrials.gov 248.525
Статус неизвестен Фаза I–II Россия
Multiple systemic (i.v.) administration of allogenic non-related group- and rhesus-compatible mononuclear cord blood cells · Sklifosovsky Institute of Emergency Care

Systemic Administration of Allogenic Mononuclear Cord Blood Cells in Patients With Acute Severe Contusion Spinal Cord Injury: Safety and Efficiency Evaluation, Stages I/II

Москва 1 центр 80 участников во всех странах ClinicalTrials.gov 007-2022
Идёт Фаза II Россия
Docetaxel; Paclitaxel; Pertuzumab; Trastuzumab; Trastuzumab Emtansine; Atezolizumab · Genentech, Inc.

An Open-Label, Multicenter Extension Study of Trastuzumab Emtansine Administered as a Single Agent or in Combination With Other Anti-Cancer Therapies in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd-Sponsored Trastuzumab Emtansine Study

Москва, Санкт-Петербург и ещё 2 города 7 центров 378 участников во всех странах ClinicalTrials.gov TDM4529g
Статус неизвестен Россия
Sosudi3 · Meshalkin Research Institute of Pathology of Circulation

Efficacy and Safety Comparison of the Endovascular (Recanalization With Angioplasty and Stenting With Biomimetic Interwoven Nitinol Stent) and the Hybrid (Recanalization With Angioplasty and Stenting With Biomimetic Interwoven Nitinol Stent, Supplemented With Fasciotomy in Hunter's Canal) Surgical Methods for the Treatment of Prolonged Atherosclerotic Lesions of the Femoral-popliteal Segment Above the Knee, TASC II, Type D

Новосибирск 1 центр 100 участников во всех странах ClinicalTrials.gov Sosudi3
Завершено Фаза III Россия
Ofloxacin; Avelox (Moxifloxacin, BAY12-8039) · Байер АГ

Prospective, Randomized, Double-blind, Multicenter, Multinational Study Comparing Efficacy and Safety of Moxifloxacin 400 mg po od for 14 Days With Ofloxacin 400 mg po Bid Plus Metronidazole 500 mg po Bid for 14 Days in Patients With Uncomplicated Pelvic Inflammatory Disease (PID)

749 участников во всех странах ClinicalTrials.gov 10995
Завершено Фаза III Россия
Paclitaxel; NOV-002; Carboplatin · Cellectar Biosciences, Inc.

Phase 3 Trial, Randomized, Open-Label, of NOV-002 in Combination With Paclitaxel and Carboplatin vs. Paclitaxel and Carboplatin Alone for the Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC)

Санкт-Петербург, Tatarstan и ещё 10 городов 15 центров 903 участника во всех странах ClinicalTrials.gov NOV002-C301
Статус неизвестен Фаза II Россия
LY2608204; Glimepiride · Эли Лилли энд Компани

A 12-Week, Phase 2, Randomized, Double-Blind, Active-Controlled Study of LY2608204 Given as Monotherapy or in Combination With Metformin in Patients With Type 2 Diabetes Mellitus

240 участников во всех странах ClinicalTrials.gov 14090

Изменения не сохранены

На этой странице есть несохранённые изменения. Если уйти со страницы, они пропадут.